Robert Hoover, MD, MPH
CIGNA Government Services
Robert Hoover, Jr., MD, MPH, is Jurisdiction C Durable Medical Equipment Medical Director at CIGNA Government Services. In his role at CIGNA Government Services, he is responsible for coverage, coding, and documentation for durable medical equipment, orthotics and prosthetics in fee-for-service Medicare. Dr. Hoover also serves on CIGNA's commercial insurance technology assessment committee as the DME subject matter expert. He has extensive experience in market dynamics related to respiratory therapy products (oxygen, CPAP, ventilators, nebulizers, and inhalation drugs); seating and mobility products (wheelchairs, scooters); wound care (KCI VAC, dressings); and others. Dr. Hoover is knowledgeable on the impact of legislative and regulatory changes in Medicare and other third party payers. Prior to rejoining CIGNA, he was Chief Medical Officer with DeVilbiss Healthcare, a division of Sunrise Medical, one of the world's largest manufacturers of homecare and extended care products. (This is me - Update Profile)
| 2008 - present | Senior Medical Director CIGNA Government Services |
|---|---|
| 2007 - 2008 | Chief Medical Officer-Independent Contractor DeVilbiss Healthcare |
| 2005 - 2007 | Senior VP of Global Clinical Services Sunrise Medical, Inc. |
GLG Study Groups with Robert Hoover, MD, MPH(?)
| Study Group Name | Members |
|---|---|
| Distributors of Durable Medical Equipments | 50 |
| Generic Drug Economic Experts | 677 |
| Economic Experts on Managed Care | 657 |
| Medicare Experts | 448 |
GLG NewsSM Analyses by Robert Hoover, MD, MPH(?)
On May 11, 2007, CMS issued a request for information proposing to eliminate the current Program Safeguard Contractors (PSC) and replace them with contractor that would be responsible fraud and abuse prevention for all lines of Medicare business – Parts A, B, C, D, Medi-Medi, DME and Home Health. The...
This is an intriguing move on the part of SNN to acquire BlueSky and get into the lucrative market of negative pressure wound therapy (NPWT), a market dominated by KCI's V.A.C therapy. BlueSky's product, Versatile 1, is significantly less expensive to produce and with the financial backing and...
GLG InstituteSM Seminars with Robert Hoover, MD, MPH(?)
View all GLG InstituteSM Seminars in Healthcare
Request a project with Robert Hoover, MD, MPH
Note: GLG Experts do not provide personal medical advice, diagnosis or treatment through this site.
GLG's 750+ Clients Include:
global mutual funds
global banks
private equity firms